Corticosteroid-induced remission, and mycophenolate maintenance therapy in GLILD: long-term, longitudinal change in lung function in a single centre cohort
H. Bintalib (London, United Kingdom), D. Lowe (London, United Kingdom), G. Mancuso (Milan, Italy), G. Gkrepi (Ioannina, Greece), S. Seneviratne (London, United Kingdom), S. Burns (London, United Kingdom), J. Hurst (London, United Kingdom)
Source: International Congress 2022 – Sarcoidosis: challenges in the assessment and management of disease complications
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Bintalib (London, United Kingdom), D. Lowe (London, United Kingdom), G. Mancuso (Milan, Italy), G. Gkrepi (Ioannina, Greece), S. Seneviratne (London, United Kingdom), S. Burns (London, United Kingdom), J. Hurst (London, United Kingdom). Corticosteroid-induced remission, and mycophenolate maintenance therapy in GLILD: long-term, longitudinal change in lung function in a single centre cohort. 3435
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|